BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 16450726)

  • 1. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mistletoe and cancer: controversies and perspectives.
    Mansky PJ
    Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mistletoe in the treatment of cancer].
    Bruseth S; Enge A
    Tidsskr Nor Laegeforen; 1993 Mar; 113(9):1058-60. PubMed ID: 8493669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mistletoe lectin is not the only cytotoxic component in fermented preparations of Viscum album from white fir (Abies pectinata).
    Eggenschwiler J; von Balthazar L; Stritt B; Pruntsch D; Ramos M; Urech K; Rist L; Simões-Wüst AP; Viviani A
    BMC Complement Altern Med; 2007 May; 7():14. PubMed ID: 17493268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric medulloblastoma cells are susceptible to Viscum album (Mistletoe) preparations.
    Zuzak TJ; Rist L; Eggenschwiler J; Grotzer MA; Viviani A
    Anticancer Res; 2006; 26(5A):3485-92. PubMed ID: 17094471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vysorel/Isorel--cancer drug from Viscum album. Documentation No.20].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Mar; 79(11):332-4. PubMed ID: 2315589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of long-term complementary treatment with standardized European mistletoe extract (Viscum album L.) in addition to the conventional adjuvant oncologic therapy in patients with primary non-metastasized mammary carcinoma. Results of a multi-center, comparative, epidemiological cohort study in Germany and Switzerland].
    Bock PR; Friedel WE; Hanisch J; Karasmann M; Schneider B
    Arzneimittelforschung; 2004; 54(8):456-66. PubMed ID: 15460213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mistletoe in conventional oncological practice: exemplary cases.
    Legnani W
    Integr Cancer Ther; 2008 Sep; 7(3):162-71. PubMed ID: 18956494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

  • 11. Case reports of sarcoma patients with optimized lectin-oriented mistletoe extract therapy.
    Kirsch A; Hajto T
    J Altern Complement Med; 2011 Oct; 17(10):973-9. PubMed ID: 22010781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mistletoe in the treatment of cancer patients].
    Rostock M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to mistletoe (Viscum album L.) in cancer patients: a four-case series.
    Gardin NE
    Phytother Res; 2009 Mar; 23(3):407-11. PubMed ID: 19003944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of mistletoe (Viscum album L.) extract on Jurkat cells and its interaction with doxorubicin.
    Sabová L; Pilátová M; Szilagyi K; Sabo R; Mojzis J
    Phytother Res; 2010 Mar; 24(3):365-8. PubMed ID: 19610041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
    Melzer J; Iten F; Hostanska K; Saller R
    Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Iscucin--mistletoe preparations for the pre- and postoperative treatment of malignancies. Documentation No. 21].
    Kast A; Hauser SP
    Schweiz Rundsch Med Prax; 1990 Apr; 79(14):427-9. PubMed ID: 2343229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
    Grossarth-Maticek R; Ziegler R
    Eur J Med Res; 2008 Mar; 13(3):107-20. PubMed ID: 18499556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic effects of the Viscum album L. extract on Ehrlich tumour cells in vivo.
    Cebović T; Spasić S; Popović M
    Phytother Res; 2008 Aug; 22(8):1097-103. PubMed ID: 18570233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
    Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
    Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
    Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
    Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.